Baxter

Companies Baxter

News Baxter

• Takeda Announces New Initiative in Cell Culture-Based Influenza Vaccines

  Takeda Pharmaceutical Company Limited announced that it has received an official notice from the Pharmaceutical Development Support Center with regard to the granting of a government subsidy for which it had applied. Takeda was notified in writing on July 6 of this decision, and the company has now more

• Kuros completes patient recruitment in a phase IIb trial of KUR-113 in patients with tibial shaft fractures

  Kuros Biosurgery AG announced that it has completed recruitment in a 200 patient Phase IIb clinical trial designed to assess the efficacy and safety of KUR-113 (Viz.I-040202) in open tibial shaft fractures. This study is a randomized, controlled, open-label (dose-blinded) dose finding study of the more

• OncoMethylome shareholders pass all resolutions at AGM and appoint three new independent directors

  OncoMethylome Sciences SA announced that its Annual General Shareholders' Meeting (AGM) held on 28 May, 2010, approved the appointment of Ms. Hilde Windels, Mr. Edward L. Erickson, and Mr. Mark Myslinski to the Board of Directors, as well as all other agenda items of the AGM. The appointment of the more

Publications Baxter

• Cyanuric acid hydrolase: evolutionary innovation by structural concatenation

  Summary The cyanuric acid hydrolase, AtzD, is the founding member of a newly identified family of ring‐opening amidases. We report the first X‐ray structure for this family, which is a novel fold (termed the ‘Toblerone’ fold) that likely evolved via the concatenation of monomers of the trimeric more

• Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy

  Accumulated data from animal models and human cancer patients strongly support the concept that the immune system can identify and control nascent tumor cells in a process called cancer immunosurveillance. In addition, the immune system can also promote tumor progression through chronic inflammati more

• Economic aspects of post‐border weed risk management

  Abstract Aim Decision‐making in weed management involves consideration of limited budgets, long time horizons, conflicting priorities, and as a result, trade‐offs. Economics provides tools that allow these issues to be addressed and is thus integral to management of the risks posed by weeds. O more

Market studies Baxter

• Czech Republic Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters

  Introduction GlobalData’s new report, “Czech Republic Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters” provides key market data on the Czech Republic Nephrology and Urology Devices market. The report provides value (USD milli more

• Sweden Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

  Introduction GlobalData’s new report, “Sweden Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others” provides key market data on the Sweden Wound Care Management market. The report provides value (USD million), volume (un more

• Puerto Rico Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: Puerto Rico is struggling to retain its reputation as a pharmaceutical manufacturing hub, with a number of plants found to be in breach of regulations and standards over recent years. Additionally, the flagging economy is expected to push skilled staff to emigrate, leaving fewer candidates more

Websites Baxter